Contact
searchSearch
HMP Global

July 2011 - FRMC

Feature
ACIP Issues Updated Recommendations for Use of Tdap Vaccine
07/19/2011
Tori Socha
The Journal of the American Medical Association presented a summary of a Morbidity and Mortality Weekly Report from the CDC.
The Journal of the American Medical Association presented a summary of a Morbidity and Mortality Weekly Report from the CDC.
The Journal of the American...
07/19/2011
First Report Managed Care
Feature
Whole-Genome and Social-Network Analysis of a Tuberculosis Outbreak in Canada
07/19/2011
Kevin L. Carter
In the Canadian province of British Columbia, the 2007 incidence of Mycobacterium tuberculosis exceeded the Canadian national average.
In the Canadian province of British Columbia, the 2007 incidence of Mycobacterium tuberculosis exceeded the Canadian national average.
In the Canadian province of...
07/19/2011
First Report Managed Care
Feature
No Metabolic Effects with Novel Antiepileptic Drug
07/19/2011
Christin Melton
Treatment-related metabolic effects are a concern for adults who depend on long-term drug therapy to prevent seizures.
Treatment-related metabolic effects are a concern for adults who depend on long-term drug therapy to prevent seizures.
Treatment-related metabolic...
07/19/2011
First Report Managed Care
Feature
Investigators Update 2-Year Data on Safinamide Use in Parkinson’s Disease Patients
07/19/2011
Christin Melton
Honolulu—A 2-year trial of patients with Parkinson’s disease (PD) and motor fluctuations found the addition of daily safinamide increased the amount of time each day in which patients experienced symptom relief with levodopa (ON time) and...
Honolulu—A 2-year trial of patients with Parkinson’s disease (PD) and motor fluctuations found the addition of daily safinamide increased the amount of time each day in which patients experienced symptom relief with levodopa (ON time) and...
Honolulu—A 2-year trial of...
07/19/2011
First Report Managed Care
Feature
Fingolimod Reduces Likelihood and Severity of Relapse in MS Patients
07/19/2011
Christin Melton
Honolulu—An analysis of data from two phase 3 studies, presented at a poster session during the AAN meeting, found oral fingolimod more effective at preventing relapse in patients with multiple sclerosis (MS) than interferon beta-1a or...
Honolulu—An analysis of data from two phase 3 studies, presented at a poster session during the AAN meeting, found oral fingolimod more effective at preventing relapse in patients with multiple sclerosis (MS) than interferon beta-1a or...
Honolulu—An analysis of data...
07/19/2011
First Report Managed Care
Feature
Novel MS Drug Reduces Relapse Risk in All Subgroups
07/19/2011
Christin Melton
Honolulu—The investigational drug teriflunomide demonstrated consistent reductions in rates of relapse and disease progression among patients with relapsing-remitting multiple sclerosis (MS), independent of patient demographics and disease...
Honolulu—The investigational drug teriflunomide demonstrated consistent reductions in rates of relapse and disease progression among patients with relapsing-remitting multiple sclerosis (MS), independent of patient demographics and disease...
Honolulu—The investigational...
07/19/2011
First Report Managed Care
Feature
Benefits with Fluoxetine Therapy after Ischemic Stroke
07/19/2011
Christin Melton
Honolulu—Data from the phase 3 FLAME (Fluoxetine in Motor Recovery of Patients with Acute Ischaemic Stroke) trial demonstrate that starting patients on a 20-mg dose of daily fluoxetine promptly after an ischemic stroke contributes to better...
Honolulu—Data from the phase 3 FLAME (Fluoxetine in Motor Recovery of Patients with Acute Ischaemic Stroke) trial demonstrate that starting patients on a 20-mg dose of daily fluoxetine promptly after an ischemic stroke contributes to better...
Honolulu—Data from the phase 3...
07/19/2011
First Report Managed Care
Conference Insider
Managing Anaphylaxis and Food Allergy Reactions
07/19/2011
Tim Casey
An analysis of online questionnaires completed by parents of children with food allergies found that medical professionals only recognized and treated approximately one third of initial reactions to food allergies that led to anaphylaxis.
An analysis of online questionnaires completed by parents of children with food allergies found that medical professionals only recognized and treated approximately one third of initial reactions to food allergies that led to anaphylaxis.
An analysis of online...
07/19/2011
First Report Managed Care
Conference Insider
Managing Anaphylaxis and Food Allergy Reactions
07/19/2011
Tim Casey
An analysis of online questionnaires completed by parents of children with food allergies found that medical professionals only recognized and treated approximately one third of initial reactions to food allergies that led to anaphylaxis.
An analysis of online questionnaires completed by parents of children with food allergies found that medical professionals only recognized and treated approximately one third of initial reactions to food allergies that led to anaphylaxis.
An analysis of online...
07/19/2011
First Report Managed Care
Conference Insider
Epinephrine Treatment Lacking in Children with Peanut Allergies
07/19/2011
Tim Casey
San Francisco—In a study of people with allergist-confirmed peanut allergy, researchers found that healthcare facilities underprescribed epinephrine autoinjectors, and patients did not use epinephrine as often as guidelines recommended. The...
San Francisco—In a study of people with allergist-confirmed peanut allergy, researchers found that healthcare facilities underprescribed epinephrine autoinjectors, and patients did not use epinephrine as often as guidelines recommended. The...
San Francisco—In a study of...
07/19/2011
First Report Managed Care
Feature
Bortezomib to Treat Multiple Myeloma
07/19/2011
Tim Casey
Chicago—In a randomized, multicenter phase 3b trial, 3 bortezomib-based therapies had similar rates of progression-free survival and were active in treating patients with newly diagnosed multiple myeloma (MM) who were ineligible to receive...
Chicago—In a randomized, multicenter phase 3b trial, 3 bortezomib-based therapies had similar rates of progression-free survival and were active in treating patients with newly diagnosed multiple myeloma (MM) who were ineligible to receive...
Chicago—In a randomized,...
07/19/2011
First Report Managed Care
Feature
Comparison of Myeloablative Therapies for Children with High-Risk Neuroblastoma
07/19/2011
Tim Casey
Chicago—Children with high-risk neuroblastoma who took busulphan and melphalan (BUMEL) had significantly improved event-free survival and overall survival after 3 years compared with a group that received carboplatin, etoposide, and melphalan...
Chicago—Children with high-risk neuroblastoma who took busulphan and melphalan (BUMEL) had significantly improved event-free survival and overall survival after 3 years compared with a group that received carboplatin, etoposide, and melphalan...
Chicago—Children with high-risk...
07/19/2011
First Report Managed Care
Vemurafenib Plus Dacarbazine Improves Survival in Metastatic Melanoma Patients
07/19/2011
Tim Casey
Chicago—A phase 3 study presented in the plenary session at the ASCO meeting showed that patients with previously untreated metastatic melanoma who received vemurafenib plus dacarbazine (a chemotherapy agent) had prolonged survival compared...
Chicago—A phase 3 study presented in the plenary session at the ASCO meeting showed that patients with previously untreated metastatic melanoma who received vemurafenib plus dacarbazine (a chemotherapy agent) had prolonged survival compared...
Chicago—A phase 3 study...
07/19/2011
First Report Managed Care
Feature
Patients with Metastatic Melanoma Benefit from Vemurafenib
07/19/2011
Tim Casey
Chicago—Patients with untreated metastatic melanoma who took vemurafenib had significant improvements in overall and progression-free survival compared with a group that took dacarbazine, according to a phase 3 trial presented in a plenary...
Chicago—Patients with untreated metastatic melanoma who took vemurafenib had significant improvements in overall and progression-free survival compared with a group that took dacarbazine, according to a phase 3 trial presented in a plenary...
Chicago—Patients with untreated...
07/19/2011
First Report Managed Care
Feature
Ruxolitinib in Patients with Myelofibrosis
07/19/2011
Tim Casey
Chicago—A phase 3 trial found that ruxolitinib showed a clinical benefit in reducing spleen size and significantly improved disease-related symptoms, functioning, and quality of life in patients with myelofibrosis compared with the best...
Chicago—A phase 3 trial found that ruxolitinib showed a clinical benefit in reducing spleen size and significantly improved disease-related symptoms, functioning, and quality of life in patients with myelofibrosis compared with the best...
Chicago—A phase 3 trial found...
07/19/2011
First Report Managed Care
Feature
Abiraterone Acetate Improves Survival in Prostate Cancer Patients
07/19/2011
Tim Casey
Chicago—A phase 3 study found that patients taking abiraterone acetate had a median increase in survival of 4.5 months compared with placebo and that the level of circulating tumor cells (CTCs) correlated with survival. Howard Scher, MD, the...
Chicago—A phase 3 study found that patients taking abiraterone acetate had a median increase in survival of 4.5 months compared with placebo and that the level of circulating tumor cells (CTCs) correlated with survival. Howard Scher, MD, the...
Chicago—A phase 3 study found...
07/19/2011
First Report Managed Care
Feature
Combination of Erlotinib and Pemetrexed to Treat Non–Small-Cell Lung Cancer
07/19/2011
Tim Casey
Chicago—A multicenter, open-label, randomized phase 2 study found that patients with nonsquamous, non–small-cell lung cancer (NSCLC) who took erlotinib and pemetrexed as a second-line treatment had significant improvements in overall survival...
Chicago—A multicenter, open-label, randomized phase 2 study found that patients with nonsquamous, non–small-cell lung cancer (NSCLC) who took erlotinib and pemetrexed as a second-line treatment had significant improvements in overall survival...
Chicago—A multicenter,...
07/19/2011
First Report Managed Care
Feature
3 Years versus 1 Year of Imatinib Treatment in Patients with GISTs
07/19/2011
Tim Casey
Patients with high-risk gastrointestinal stromal tumors who received imatinib after undergoing surgery had improved survival.
Patients with high-risk gastrointestinal stromal tumors who received imatinib after undergoing surgery had improved survival.
Patients with high-risk...
07/19/2011
First Report Managed Care
Feature
Exemestane Reduces Breast Cancer Risk for Postmenopausal Women
07/19/2011
Tim Casey
Chicago—A randomized, double-blind, placebo-controlled, phase 3 study presented in an oral abstract session at the ASCO meeting revealed that exemestane reduced the risk of invasive breast cancer by 65% in postmenopausal women who are at high...
Chicago—A randomized, double-blind, placebo-controlled, phase 3 study presented in an oral abstract session at the ASCO meeting revealed that exemestane reduced the risk of invasive breast cancer by 65% in postmenopausal women who are at high...
Chicago—A randomized,...
07/19/2011
First Report Managed Care
Feature
Bevacizumab Superior to Placebo in Treating Ovarian Cancer Patients
07/19/2011
Tim Casey
Chicago—At a median follow-up of 24 months, patients with recurrent platinum-sensitive ovarian cancer who took bevacizumab in combination with chemotherapy had a 52% reduction in the risk of disease progression and a 4-month increase in...
Chicago—At a median follow-up of 24 months, patients with recurrent platinum-sensitive ovarian cancer who took bevacizumab in combination with chemotherapy had a 52% reduction in the risk of disease progression and a 4-month increase in...
Chicago—At a median follow-up of...
07/19/2011
First Report Managed Care
Feature
Clinical Decision-Support Systems and Electronic Health Records
07/18/2011
Tori Socha
Since 1991, the Institute of Medicine has recommended use of electronic health records (EHRs) as a way to improve the quality of healthcare. Clinical practices using outpatient EHRs report improved clinical decisions and better communication...
Since 1991, the Institute of Medicine has recommended use of electronic health records (EHRs) as a way to improve the quality of healthcare. Clinical practices using outpatient EHRs report improved clinical decisions and better communication...
Since 1991, the Institute of...
07/18/2011
First Report Managed Care
Feature
Medicare Expenditures at End of Life in Patients with Advanced Dementia
07/18/2011
Tori Socha
Among older Americans, dementia is a leading cause of death.
Among older Americans, dementia is a leading cause of death.
Among older Americans, dementia...
07/18/2011
First Report Managed Care
News Connection
Association of Medication Regimen Complexity and Patient Adherence
07/18/2011
Tori Socha
Patients with ≥1 chronic diseases often require complex therapeutic regimens involving frequent daily dosing and multiple medications. Regimen complexity may undermine effective chronic disease management; patients taking medications that...
Patients with ≥1 chronic diseases often require complex therapeutic regimens involving frequent daily dosing and multiple medications. Regimen complexity may undermine effective chronic disease management; patients taking medications that...
Patients with ≥1 chronic...
07/18/2011
First Report Managed Care
Feature
Prescribed Dose and Unintentional Opioid Overdose Mortality
07/18/2011
Tori Socha
In the past 10 years, the rate of overdose mortality has had a sharp increase in the United States, creating an urgent health problem, according to researchers. From 1999 through 2007, the rate of unintentional overdose death increased by...
In the past 10 years, the rate of overdose mortality has had a sharp increase in the United States, creating an urgent health problem, according to researchers. From 1999 through 2007, the rate of unintentional overdose death increased by...
In the past 10 years, the rate...
07/18/2011
First Report Managed Care
Feature
Outcomes after Stopping Conjugated Equine Estrogens in Postmenopausal Women
07/18/2011
Tori Socha
The effects of conjugated equine estrogens (CEEs) on the incidence of chronic disease among postmenopausal women with prior hysterectomy were evaluated in the Women’s Health Initiative Estrogen-Alone Trial. The double-blind,...
The effects of conjugated equine estrogens (CEEs) on the incidence of chronic disease among postmenopausal women with prior hysterectomy were evaluated in the Women’s Health Initiative Estrogen-Alone Trial. The double-blind,...
The effects of conjugated equine...
07/18/2011
First Report Managed Care
Feature
Initial Plan Released to Meet Affordable Care Act Requirements
07/18/2011
Jill Sederstorm
A new strategic plan developed by the secretary of the Department of Health and Human Services (DHHS) has been released to address how the Affordable Care Act’s mission of increasing high-quality and affordable healthcare will be accomplished...
A new strategic plan developed by the secretary of the Department of Health and Human Services (DHHS) has been released to address how the Affordable Care Act’s mission of increasing high-quality and affordable healthcare will be accomplished...
A new strategic plan developed...
07/18/2011
First Report Managed Care
Feature
New Reports Highlight Out-of-Pocket Costs for Medicare Beneficiaries
07/18/2011
Jill Sederstorm
The Kaiser Family Foundation released 3 new reports that highlight the current out-of-pocket costs for Medicare beneficiaries and what may lie ahead for the future.
The Kaiser Family Foundation released 3 new reports that highlight the current out-of-pocket costs for Medicare beneficiaries and what may lie ahead for the future.
The Kaiser Family...
07/18/2011
First Report Managed Care
Feature
Preventing Conversion to Diabetes from Impaired Glucose Tolerance
07/18/2011
Tori Socha
Twenty-one million Americans are affected by type 2 diabetes mellitus, and the prevalence of the disease is increasing. Type 2 diabetes begins with a genetic predisposition and progresses from normal glucose tolerance with insulin resistance...
Twenty-one million Americans are affected by type 2 diabetes mellitus, and the prevalence of the disease is increasing. Type 2 diabetes begins with a genetic predisposition and progresses from normal glucose tolerance with insulin resistance...
Twenty-one million Americans are...
07/18/2011
First Report Managed Care
Feature
The PROTECT Study: Dalteparin versus Unfractionated Heparin
07/18/2011
Tori Socha
Patients in the intensive care unit (ICU) are at risk for venous thromboembolism, a serious complication of critical illness, as well as the need for life support measures, sedation, analgesia and paralysis, central venous catheterization,...
Patients in the intensive care unit (ICU) are at risk for venous thromboembolism, a serious complication of critical illness, as well as the need for life support measures, sedation, analgesia and paralysis, central venous catheterization,...
Patients in the intensive care...
07/18/2011
First Report Managed Care
Feature
Americans Support Minor Reductions in Medicare Spending
07/18/2011
The June 2011 tracking poll conducted by the Henry J. Kaiser Family Foundation examined the opinions of seniors and the general public on the debate over how to deal with the federal budget deficit and the related discussions about the...
The June 2011 tracking poll conducted by the Henry J. Kaiser Family Foundation examined the opinions of seniors and the general public on the debate over how to deal with the federal budget deficit and the related discussions about the...
The June 2011 tracking poll...
07/18/2011
First Report Managed Care
Feature
McKinsey, Politicians Clash over Health Insurance Report
07/18/2011
Tim Casey
For months, President Barack Obama’s administration and healthcare reform advocates cited studies indicating most people would continue receiving insurance from their employers when the major Patient Protection and Affordable Care Act (ACA)...
For months, President Barack Obama’s administration and healthcare reform advocates cited studies indicating most people would continue receiving insurance from their employers when the major Patient Protection and Affordable Care Act (ACA)...
For months, President Barack...
07/18/2011
First Report Managed Care
Feature
Government Cracks Down on Healthcare, Medicare Fraud
07/18/2011
Tim Casey
Throughout the United States, physicians and other healthcare professionals work together or with criminals on elaborate schemes. Their goal? Defraud the government and receive money for illegal Medicare and health claims. The efforts have...
Throughout the United States, physicians and other healthcare professionals work together or with criminals on elaborate schemes. Their goal? Defraud the government and receive money for illegal Medicare and health claims. The efforts have...
Throughout the United States,...
07/18/2011
First Report Managed Care

Pipeline Projections

PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care
Pipeline Projections
How Biosimilars Are Shaping RA Treatment and Reimbursement Strategies
04/29/2025
Roy Moore
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline...
04/29/2025
First Report Managed Care

Subscribe to receive the latest updates in managed care!

First Report Managed Care Newsletter

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

July 2011 Volume 8 Issue 7

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use